semaglutide diabetes trial A 72-week compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the 🧪 New Phase 2 Trial:

Individual outcomes using Ozempic can vary based on numerous factors, including dosage, adherence, lifestyle choices, and baseline weight

It is important to talk to your healthcare provider to determine if Semaglutide is a good option for you

Long-term weight reduction and metabolic improvements generally become more stable after 6 months of continuous use

36 Months The full effects of treatment usually manifest within this period

Choe HJ, Cho YM

Hyperglycemia can lead to a host of different pathologies from cardiovascular disease to different skin conditions to depression, so its crucial that glucose levels be regulated in the body